Baseline Performance and Fitting Parameters for Sonova Products

Sponsor
Advanced Bionics (Industry)
Overall Status
Enrolling by invitation
CT.gov ID
NCT05859568
Collaborator
(none)
20
1
1
60
0.3

Study Details

Study Description

Brief Summary

The purpose of this study is to assess the effectiveness and optimization of various FDA approved products.

Condition or Disease Intervention/Treatment Phase
  • Device: Pinna-located microphone
  • Device: Pinna-simulated microphone algorithm
N/A

Detailed Description

This study uses a prospective within-subjects repeated-measures design in which each subject serves as her/his own control. The purpose of this study is to assess the effectiveness and optimization of various FDA approved hardware, signal preprocessing and processing software, fitting characteristics, and service delivery methods, such as remote support and/or tele-audiology on an expanded subject demographic. The insights gained from this study will be used to optimize listening configuration recommendations, refine audiological practice, and inform future innovations.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
20 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Baseline Performance and Fitting Parameters for Sonova Products
Actual Study Start Date :
Apr 17, 2023
Anticipated Primary Completion Date :
Apr 17, 2028
Anticipated Study Completion Date :
Apr 17, 2028

Arms and Interventions

Arm Intervention/Treatment
Experimental: Microphone Location versus Microphone Algorithm Comparison

Comparing performance and subjective feedback for pinna-located microphone versus a pinna-simulated microphone algorithm.

Device: Pinna-located microphone
Sound processors using a pinna-located microphone

Device: Pinna-simulated microphone algorithm
Sound processors using a pinna-simulated algorithm

Outcome Measures

Primary Outcome Measures

  1. Speech performance in noise [1 day]

    The primary efficacy endpoint is recorded AzBio sentences presented from a single loud speaker at 60 dBA. The recognition scores using the pinna-located microphone in quiet and noise captured at initial visit will be compared to the AzBio sentence recognition scores using the pinna-simulated microphone. Scores are determined on a scale of 0% to 100% words correct with higher scores indicating a better outcome.

Secondary Outcome Measures

  1. Localization performance [1 day]

    A secondary efficacy endpoint is a front/back localization task where filtered pink noise is presented at 60dBA from one of six speakers in a 360 degree array. Scores are generated in percent correct; the scores obtained from the pinna-located microphone will be compared to the localization scores using the pinna-simulated microphone.

  2. Analysis of usability and preference questionnaire [8 weeks]

    Subject responses captured on a usability and preference questionnaire at the initial visit will be compared to responses on the questionnaire administered after each two-week chronic use interval. Questions will inquire about subject's ability and experience hearing and listening in different situations and wearing configuration preferences. The questions are rated on a 5-point Likert scale with varying strength, such as "It was easy to verify proper microphone function" with answers ranging from strongly disagree to strongly agree.

Eligibility Criteria

Criteria

Ages Eligible for Study:
8 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Ability to provide Informed Consent/Assent

  • Adults (age +18 years) and children (8-17 years) can be enrolled in this study

  • If child is aged 8-17 years, an assent will be completed, and the subject must be accompanied by a parent or legal guardian for all study activities

  • Have the functional capability to operate the controls for the device and to comply with all directions during the study as determined by the investigator conducting the consent/baseline visit

  • English language proficiency as determined by the investigator

Exclusion Criteria:

• Have any significant medical condition that, in the opinion of any of the investigators, is likely to interfere with study procedures or likely to confound evaluation of study endpoints

Contacts and Locations

Locations

Site City State Country Postal Code
1 Advanced Bionics Valencia California United States 91355

Sponsors and Collaborators

  • Advanced Bionics

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Advanced Bionics
ClinicalTrials.gov Identifier:
NCT05859568
Other Study ID Numbers:
  • CPR2301
First Posted:
May 16, 2023
Last Update Posted:
May 16, 2023
Last Verified:
May 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
Yes
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 16, 2023